Site içinde arama yapın | Friends - Best Social Network

Kan Kumar bir ses eklendi Other
2025-07-02 12:30:31

Opportunities and Challenges in the Duchenne Muscular Dystrophy Therapeutics Market
Duchenne Muscular Dystrophy constitutes the most prevalent childhood muscular dystrophy, affecting approximately one in 3,500 male births globally. This devastating X-linked disorder results from dystrophin gene mutations that prevent normal muscle fiber maintenance, leading to progressive weakness, mobility loss, and premature mortality from cardiopulmonary complications. Recent therapeutic...

0 Yorumlar 0 hisse senetleri 137 Views 0 önizleme

Please log in to like, share and comment!
Devidi Jahnavi bir ses eklendi Health
2025-06-17 07:02:31

The Role of CRISPR and AAV in Duchenne Gene Repair
Duchenne Muscular Dystrophy (DMD) is a rare, progressive neuromuscular disorder that leads to severe muscle degeneration and early mortality. Affecting roughly 1 in 3,500 to 5,000 male births globally, DMD stems from mutations in the DMD gene, which encodes dystrophin, a protein critical for muscle fiber integrity. Without dystrophin, muscle cells become fragile and eventually die, leading to...

0 Yorumlar 0 hisse senetleri 278 Views 0 önizleme

Please log in to like, share and comment!
Uttej Netha bir ses eklendi Health
2025-07-01 04:53:54

High Therapy Costs Remain Barrier Despite Market Growth to USD 8.84B
The North America Duchenne Muscular Dystrophy (DMD) Treatment Market is set for significant growth, expanding from USD 2.06 billion in 2024 to USD 8.84 billion by 2033, at an impressive compound annual growth rate (CAGR) of 20.2% during the period 2025–2033. Download Sample Report:...

0 Yorumlar 0 hisse senetleri 275 Views 0 önizleme

Please log in to like, share and comment!